Work

A Phase 1b Clinical Trial of Dacetuzumab in Combination with Rituximab and Gemcitabine: Multiple Responses Observed in Patients with Relapsed Diffuse Large B-Cell Lymphoma.

Year: 2009

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v114.22.586.586

Authors: Andres Forero-Torres, Nancy L Bartlett, Sunita D Nasta, Donald Northfelt, Anne Beaven, Han Myint, Nancy C Whiting, Jonathan G Drachman, Craig H Moskowitz

Institutions: University of Alabama at Birmingham, Washington University in St. Louis, Abramson Cancer Center, University of Pennsylvania, Mayo Clinic in Arizona, Duke Medical Center, Seagen (United States), Memorial Sloan Kettering Cancer Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2583881072

FWCI: 1.26

Cites:

Cited by: 7

Related to: 10